Back
Structure Therapeutics Stock Predictions
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
GPCR
Structure Therapeutics
Last Price:
$23.77
Seasonality Move:
18.95%
7 Day Trial
ALL ACCESS PASS
$
7
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Structure Therapeutics Stock Forecast
-
Over the next 52 weeks, Structure Therapeutics has on average historically risen by 4.4% based on the past 2 years of stock performance.
-
Structure Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Structure Therapeutics Stock Undervalued?The current Structure Therapeutics [GPCR] share price is $23.74. The Score for GPCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
GPCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Structure Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Structure Therapeutics has on average historically risen by 4.4% based on the past 2 years of stock performance.
Structure Therapeutics Stock Rating
Sell
44
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics overpriced?
-
Structure Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Structure Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
structuretx.com
52-Week Data
52-Week High:
62.74
52-Week Low:
13.22
Prediction Charts
Market Cap:
1.4B
Price in USD:
23.74
Volume:
731.8K
Beta:
-1.45
Technical Analysis
SMA50:
20.57
SMA100:
24.86
SMA200:
31.59
52-Wk Change:
-39.1%
Stock Predictions
-
Is Structure Therapeutics stock public?Yes, Structure Therapeutics is a publicly traded company.
-
What is the Structure Therapeutics stock quote today?The Structure Therapeutics stock price is 23.74 USD today.
-
How to buy Structure Therapeutics stock online?You can buy Structure Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-7 | 14.46 | 14.31 | 15.53 | 13.73 |
| Apr-8 | 14.89 | 14.15 | 15.45 | 13.95 |
| Apr-9 | 13.73 | 15.27 | 15.98 | 13.22 |
| Apr-10 | 14.94 | 15.05 | 15.58 | 14.42 |
| Apr-11 | 15.10 | 15.90 | 16.06 | 15.00 |
| Apr-14 | 18.00 | 18.95 | 19.23 | 16.80 |
| Apr-15 | 18.80 | 18.90 | 19.78 | 18.52 |
| Apr-16 | 18.71 | 18.53 | 18.90 | 17.94 |
| Apr-17 | 21.50 | 21.76 | 24.17 | 19.74 |
| Apr-21 | 21.57 | 23.10 | 23.94 | 21.01 |
| Apr-22 | 23.17 | 23.04 | 23.34 | 21.86 |
| Apr-23 | 23.57 | 23.32 | 24.45 | 23.05 |
| Apr-24 | 23.21 | 23.65 | 24.00 | 22.79 |
| Apr-25 | 23.50 | 23.74 | 24.19 | 23.20 |
Structure Therapeutics Earnings
Structure Therapeutics Earnings Report: Per Share Structure Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Structure Therapeutics Forecast Revenue Growth
Structure Therapeutics Stock Analysis: Historical quarterly revenues per share for Structure Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.08 per share, and a decrease next year of $0.68 per share.
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.